Affinity Asset Advisors, LLC Novo Cure LTD Transaction History
Affinity Asset Advisors, LLC
- $579 Million
- Q3 2024
A detailed history of Affinity Asset Advisors, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 25,000 shares of NVCR stock, worth $654,250. This represents 0.75% of its overall portfolio holdings.
Number of Shares
25,000Holding current value
$654,250% of portfolio
0.75%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NVCR
# of Institutions
262Shares Held
76.9MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$318 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$310 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$207 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$113 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$79.3 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.75B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...